1
|
Yan H, Chen F. Recent Progress in Solid‐Phase Total Synthesis of Naturally Occurring Small Peptides. Adv Synth Catal 2022. [DOI: 10.1002/adsc.202200079] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- Hong Yan
- Institute of Pharmaceutical Science and Technology College of Chemistry Fuzhou University Fuzhou 350108 People's Republic of China
| | - Fen‐Er Chen
- Institute of Pharmaceutical Science and Technology College of Chemistry Fuzhou University Fuzhou 350108 People's Republic of China
- Engineering Center of Catalysis and Synthesis for Chiral Molecules Department of Chemistry Fudan University 220 Handan Road Shanghai 200433 People's Republic of China
- Shanghai Engineering Research Center of Industrial Asymmetric Catalysis of Chiral Drugs Fudan University 220 Handan Road Shanghai 200433 People's Republic of China
| |
Collapse
|
2
|
Li W, Separovic F, O'Brien-Simpson NM, Wade JD. Chemically modified and conjugated antimicrobial peptides against superbugs. Chem Soc Rev 2021; 50:4932-4973. [PMID: 33710195 DOI: 10.1039/d0cs01026j] [Citation(s) in RCA: 222] [Impact Index Per Article: 74.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Antimicrobial resistance (AMR) is one of the greatest threats to human health that, by 2050, will lead to more deaths from bacterial infections than cancer. New antimicrobial agents, both broad-spectrum and selective, that do not induce AMR are urgently required. Antimicrobial peptides (AMPs) are a novel class of alternatives that possess potent activity against a wide range of Gram-negative and positive bacteria with little or no capacity to induce AMR. This has stimulated substantial chemical development of novel peptide-based antibiotics possessing improved therapeutic index. This review summarises recent synthetic efforts and their impact on analogue design as well as their various applications in AMP development. It includes modifications that have been reported to enhance antimicrobial activity including lipidation, glycosylation and multimerization through to the broad application of novel bio-orthogonal chemistry, as well as perspectives on the direction of future research. The subject area is primarily the development of next-generation antimicrobial agents through selective, rational chemical modification of AMPs. The review further serves as a guide toward the most promising directions in this field to stimulate broad scientific attention, and will lead to new, effective and selective solutions for the several biomedical challenges to which antimicrobial peptidomimetics are being applied.
Collapse
Affiliation(s)
- Wenyi Li
- Melbourne Dental School, Centre for Oral Health Research, University of Melbourne, VIC 3010, Australia. and Bio21 Institute, University of Melbourne, VIC 3010, Australia
| | - Frances Separovic
- Bio21 Institute, University of Melbourne, VIC 3010, Australia and School of Chemistry, University of Melbourne, VIC 3010, Australia
| | - Neil M O'Brien-Simpson
- Melbourne Dental School, Centre for Oral Health Research, University of Melbourne, VIC 3010, Australia. and Bio21 Institute, University of Melbourne, VIC 3010, Australia
| | - John D Wade
- School of Chemistry, University of Melbourne, VIC 3010, Australia and The Florey Institute of Neuroscience and Mental Health, University of Melbourne, VIC 3010, Australia.
| |
Collapse
|
3
|
Siow A, Kowalczyk R, Brimble MA, Harris PWR. Evolution of Peptide-Based Prostate-Specific Membrane Antigen (PSMA) Inhibitors: An Approach to Novel Prostate Cancer Therapeutics. Curr Med Chem 2021; 28:3713-3752. [PMID: 33023429 DOI: 10.2174/0929867327666201006153847] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Revised: 08/24/2020] [Accepted: 08/30/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND Prostate cancer is one of the most common cancers worldwide, with approximately 1.1 million cases diagnosed annually. The rapid development of molecular imaging has facilitated greater structural understanding, which can help formulate novel combinations of therapeutic regimens and more accurate diagnosis, avoiding unnecessary prostate biopsies. This accumulated knowledge also provides a greater understanding of the aggressive stages of the disease and tumor recurrence. Recently, much progress has been made on developing peptidomimetic-based inhibitors as promising candidates to effectively bind to the prostate- specific membrane antigen (PSMA), which is expressed by prostate cancer cells. OBJECTIVE In this review, recent advances covering small-molecule and peptide-based PSMA inhibitors will be extensively reviewed, providing a base for the rational design of future PSMA inhibitors. METHOD Herein, the literature on selected PSMA inhibitors that have been developed from 1996 to 2020 were reviewed, emphasizing recent synthetic advances and chemical strategies whilst highlighting therapeutic potential and drawbacks of each inhibitor. RESULTS Synthesized inhibitors presented in this review demonstrate the clinical application of certain PSMA inhibitors, exhibited in vitro and in vivo. CONCLUSION This review highlights the clinical potential of PSMA inhibitors, analyzing the advantages and setbacks of the chemical synthetic methodologies utilized, setting precedence for the discovery of novel PSMA inhibitors for future clinical applications.
Collapse
Affiliation(s)
- Andrew Siow
- School of Chemical Sciences, The University of Auckland, 23 Symonds Street, Private Bag: 92019, Auckland 1010, New Zealand
| | - Renata Kowalczyk
- School of Chemical Sciences, The University of Auckland, 23 Symonds Street, Private Bag: 92019, Auckland 1010, New Zealand
| | - Margaret A Brimble
- School of Chemical Sciences, The University of Auckland, 23 Symonds Street, Private Bag: 92019, Auckland 1010, New Zealand
| | - Paul W R Harris
- School of Chemical Sciences, The University of Auckland, 23 Symonds Street, Private Bag: 92019, Auckland 1010, New Zealand
| |
Collapse
|
4
|
Hanna CC, Hermant YO, Harris PWR, Brimble MA. Discovery, Synthesis, and Optimization of Peptide-Based Antibiotics. Acc Chem Res 2021; 54:1878-1890. [PMID: 33750106 DOI: 10.1021/acs.accounts.0c00841] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
The rise of multidrug resistant bacteria has significantly compromised our supply of antibiotics and poses an alarming medical and economic threat to society. To combat this problem, it is imperative that new antibiotics and treatment modalities be developed, especially those toward which bacteria are less capable of developing resistance. Peptide natural products stand as promising candidates to meet this need as bacterial resistance is typically slow in response to their unique modes of action. They also have additional benefits including favorable modulation of host immune responses and often possess broad-spectrum activity against notoriously treatment resistant bacterial biofilms. Moreover, nature has provided a wealth of peptide-based natural products from a range of sources, including bacteria and fungi, which can be hijacked in order to combat more dangerous clinically relevant infections.This Account highlights recent advances in the total synthesis and development of a range of peptide-based natural product antibiotics and details the medicinal chemistry approaches used to optimize their activity.In the context of antibiotics with potential to treat Gram-positive bacterial infections, this Account covers the synthesis and optimization of the natural products daptomycin, glycocin F, and alamethicin. In particular, the reported synthesis of daptomycin highlights the utility of on-resin ozonolysis for accessing a key kynurenine residue from the canonical amino acid tryptophan. Furthermore, the investigation into glycocin F analogues uncovered a potent lead compound against Lactobacillus plantarum that bears a non-native thioacetal linkage to a N-acetyl-d-glucosamine (GlcNAc) sugar, which is otherwise O-linked in its native form.For mycobacterial infections, this Account covers the synthesis and optimization of teixobactin, callyaerin A, lassomycin, and trichoderin A. The synthesis of callyaerin A, in particular, highlighted the importance of a (Z)-2,3-diaminoacrylamide motif for antimicrobial activity against Mycobacterium tuberculosis, while the synthesis of trichoderin A highlighted the importance of (R)-stereoconfiguration in a key 2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid (AHMOD) residue.Lastly, this Account covers lipopeptide antibiotics bearing activity toward Gram-negative bacterial infections, namely, battacin and paenipeptin C. In both cases, optimization of the N-terminal lipid tails led to the identification of analogues with potent activity toward Escherichia coli and Pseudomonas aeruginosa.
Collapse
Affiliation(s)
- Cameron C. Hanna
- School of Chemical Sciences The University of Auckland, 23 Symonds St, Auckland 1142, New Zealand
| | - Yann O. Hermant
- School of Chemical Sciences The University of Auckland, 23 Symonds St, Auckland 1142, New Zealand
- Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland 1142, New Zealand
| | - Paul W. R. Harris
- School of Chemical Sciences The University of Auckland, 23 Symonds St, Auckland 1142, New Zealand
- School of Biological Sciences, The University of Auckland, 3A Symonds St, Auckland 1142, New Zealand
- Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland 1142, New Zealand
| | - Margaret A. Brimble
- School of Chemical Sciences The University of Auckland, 23 Symonds St, Auckland 1142, New Zealand
- School of Biological Sciences, The University of Auckland, 3A Symonds St, Auckland 1142, New Zealand
- Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland 1142, New Zealand
| |
Collapse
|
5
|
Shenouda ML, Cox RJ. Molecular methods unravel the biosynthetic potential of Trichoderma species. RSC Adv 2021; 11:3622-3635. [PMID: 35424278 PMCID: PMC8694227 DOI: 10.1039/d0ra09627j] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2020] [Accepted: 01/10/2021] [Indexed: 12/14/2022] Open
Abstract
Members of the genus Trichoderma are a well-established and studied group of fungi, mainly due to their efficient protein production capabilities and their biocontrol activities. Despite the immense interest in the use of different members of this species as biopesticides and biofertilizers, the study of their active metabolites and their biosynthetic gene clusters has not gained significant attention until recently. Here we review the challenges and opportunities in exploiting the full potential of Trichoderma spp. for the production of natural products and new metabolic engineering strategies used to overcome some of these challenges.
Collapse
Affiliation(s)
- Mary L Shenouda
- OCI, BMWZ, Leibniz University of Hannover Schneiderberg 38 30167 Hannover Germany
- Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University 21521 Egypt
| | - Russell J Cox
- OCI, BMWZ, Leibniz University of Hannover Schneiderberg 38 30167 Hannover Germany
| |
Collapse
|
6
|
Cameron AJ, Davison EK, An C, Stubbing LA, Dunbar PR, Harris PWR, Brimble MA. Synthesis and SAR Analysis of Lipovelutibols B and D and Their Lipid Analogues. J Org Chem 2019; 85:1401-1406. [DOI: 10.1021/acs.joc.9b02348] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Alan J. Cameron
- School of Chemical Sciences, University of Auckland, 23 Symonds Street, Auckland, 1010, New Zealand
- School of Biological Sciences, University of Auckland, 3 Symonds Street, Auckland, 1010, New Zealand
- The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Private
Bag 92019, Auckland, 1142, New Zealand
| | - Emma K. Davison
- School of Chemical Sciences, University of Auckland, 23 Symonds Street, Auckland, 1010, New Zealand
- School of Biological Sciences, University of Auckland, 3 Symonds Street, Auckland, 1010, New Zealand
- The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Private
Bag 92019, Auckland, 1142, New Zealand
| | - Chalice An
- School of Chemical Sciences, University of Auckland, 23 Symonds Street, Auckland, 1010, New Zealand
- School of Biological Sciences, University of Auckland, 3 Symonds Street, Auckland, 1010, New Zealand
| | - Louise A. Stubbing
- School of Chemical Sciences, University of Auckland, 23 Symonds Street, Auckland, 1010, New Zealand
- The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Private
Bag 92019, Auckland, 1142, New Zealand
| | - P. Rod Dunbar
- School of Biological Sciences, University of Auckland, 3 Symonds Street, Auckland, 1010, New Zealand
- The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Private
Bag 92019, Auckland, 1142, New Zealand
| | - Paul W. R. Harris
- School of Chemical Sciences, University of Auckland, 23 Symonds Street, Auckland, 1010, New Zealand
- School of Biological Sciences, University of Auckland, 3 Symonds Street, Auckland, 1010, New Zealand
- The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Private
Bag 92019, Auckland, 1142, New Zealand
| | - Margaret A. Brimble
- School of Chemical Sciences, University of Auckland, 23 Symonds Street, Auckland, 1010, New Zealand
- School of Biological Sciences, University of Auckland, 3 Symonds Street, Auckland, 1010, New Zealand
- The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Private
Bag 92019, Auckland, 1142, New Zealand
| |
Collapse
|
7
|
Das S, Ben Haj Salah K, Djibo M, Inguimbert N. Peptaibols as a model for the insertions of chemical modifications. Arch Biochem Biophys 2018; 658:16-30. [DOI: 10.1016/j.abb.2018.09.016] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2018] [Revised: 09/05/2018] [Accepted: 09/18/2018] [Indexed: 12/13/2022]
|
8
|
Siow A, Opiyo G, Kavianinia I, Li FF, Furkert DP, Harris PWR, Brimble MA. Total Synthesis of the Highly N-Methylated Acetylene-Containing Anticancer Peptide Jahanyne. Org Lett 2018; 20:788-791. [PMID: 29337569 DOI: 10.1021/acs.orglett.7b03925] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
The first total synthesis of the highly N-methylated acetylene-containing lipopeptide jahanyne, an apoptosis-inducing natural product from marine cyanobacteria, is reported. A late-stage solution-phase coupling enabled introduction of the C-terminal ketone pyrrolidine moiety. A modified Fmoc solid-phase synthesis strategy was adopted to effectively couple multiple sterically hindered N-methylated amino acids while suppressing epimerization. The total synthesis has enabled confirmation of the proposed absolute configuration of natural jahanyne.
Collapse
Affiliation(s)
- Andrew Siow
- School of Biological Sciences, The University of Auckland , 3A Symonds Street, Auckland 1010, New Zealand
| | - George Opiyo
- School of Chemical Sciences, The University of Auckland , 23 Symonds Street, Auckland 1010, New Zealand
| | - Iman Kavianinia
- School of Biological Sciences, The University of Auckland , 3A Symonds Street, Auckland 1010, New Zealand.,Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland , 3A Symonds Street, Auckland 1010, New Zealand
| | - Freda F Li
- School of Chemical Sciences, The University of Auckland , 23 Symonds Street, Auckland 1010, New Zealand
| | - Daniel P Furkert
- School of Chemical Sciences, The University of Auckland , 23 Symonds Street, Auckland 1010, New Zealand.,Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland , 3A Symonds Street, Auckland 1010, New Zealand
| | - Paul W R Harris
- School of Biological Sciences, The University of Auckland , 3A Symonds Street, Auckland 1010, New Zealand.,Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland , 3A Symonds Street, Auckland 1010, New Zealand
| | - Margaret A Brimble
- School of Biological Sciences, The University of Auckland , 3A Symonds Street, Auckland 1010, New Zealand.,School of Chemical Sciences, The University of Auckland , 23 Symonds Street, Auckland 1010, New Zealand.,Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland , 3A Symonds Street, Auckland 1010, New Zealand
| |
Collapse
|
9
|
Tarasenko I, Zashikhina N, Guryanov I, Volokitina M, Biondi B, Fiorucci S, Formaggio F, Tennikova T, Korzhikova-Vlakh E. Amphiphilic polypeptides with prolonged enzymatic stability for the preparation of self-assembled nanobiomaterials. RSC Adv 2018; 8:34603-34613. [PMID: 35548620 PMCID: PMC9087002 DOI: 10.1039/c8ra06324a] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2018] [Accepted: 10/01/2018] [Indexed: 12/25/2022] Open
Abstract
Aib residue distribution in Lys/Aib polymers influences the morphology of forming nanoparticles and the rate of their enzymatic degradation.
Collapse
Affiliation(s)
- Irina Tarasenko
- Institute of Macromolecular Compounds
- Russian Academy of Sciences
- 199004 St Petersburg
- Russia
| | - Natalia Zashikhina
- Institute of Macromolecular Compounds
- Russian Academy of Sciences
- 199004 St Petersburg
- Russia
- Institute of Chemistry
| | - Ivan Guryanov
- Institute of Chemistry
- St Petersburg State University
- 26 Universitetskij Pr
- St Petersburg
- Russia
| | - Maria Volokitina
- Institute of Macromolecular Compounds
- Russian Academy of Sciences
- 199004 St Petersburg
- Russia
| | - Barbara Biondi
- Department of Clinical and Experimental Medicine
- University of Perugia
- 06132 Perugia
- Italy
| | | | - Fernando Formaggio
- Department of Clinical and Experimental Medicine
- University of Perugia
- 06132 Perugia
- Italy
| | - Tatiana Tennikova
- Institute of Chemistry
- St Petersburg State University
- 26 Universitetskij Pr
- St Petersburg
- Russia
| | - Evgenia Korzhikova-Vlakh
- Institute of Macromolecular Compounds
- Russian Academy of Sciences
- 199004 St Petersburg
- Russia
- Institute of Chemistry
| |
Collapse
|
10
|
Su X, Zhou X, Tan Z, Zhou C. Highly efficient antibacterial diblock copolypeptides based on lysine and phenylalanine. Biopolymers 2017; 107. [DOI: 10.1002/bip.23041] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2017] [Revised: 07/26/2017] [Accepted: 07/31/2017] [Indexed: 12/31/2022]
Affiliation(s)
- Xiaokai Su
- School of Materials Science and Engineering; Tongji University, 4800 Caoan Road; Shanghai 201804 China
| | - Xinyu Zhou
- School of Materials Science and Engineering; Tongji University, 4800 Caoan Road; Shanghai 201804 China
| | - Zhengzhong Tan
- School of Materials Science and Engineering; Tongji University, 4800 Caoan Road; Shanghai 201804 China
| | - Chuncai Zhou
- School of Materials Science and Engineering; Tongji University, 4800 Caoan Road; Shanghai 201804 China
| |
Collapse
|